Materials science and tissue engineering: repairing the heart.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 23910415.
- Also identified by DOI 10.1016/j.mayocp.2013.05.003 and PMC identifier 3786696.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Heart failure after a myocardial infarction continues to be a leading killer in the Western world. Currently, there are no therapies that effectively prevent or reverse the cardiac damage and negative left ventricular remodeling process that follows a myocardial infarction. Because the heart has limited regenerative capacity, there has been considerable effort to develop new therapies that could repair and regenerate the myocardium. Although cell transplantation alone was initially studied, more recently, tissue engineering strategies using biomaterial scaffolds have been explored. In this review, we cover the different approaches to engineering the myocardium, including cardiac patches, which are in vitro-engineered constructs of functional myocardium, and injectable scaffolds, which can either encourage endogenous repair and regeneration or act as vehicles to support the delivery of cells and other therapeutics.
Medical subject headings
- Heart Failure
- Myocytes, Cardiac
- Pluripotent Stem Cells
- Regeneration
- Tissue Engineering